MedPage Today -- The protease inhibitor darunavir (Prezista) can be given once a day to treatment-experienced HIV patients without an increased risk of resistance, researchers said here.
MedPage Today -- The protease inhibitor darunavir (Prezista) can be given once a day to treatment-experienced HIV patients without an increased risk of resistance, researchers said here.